Why The Drug Industry Faces A 3-Front Battle With The FTC, Medicare, And The White House

Big Pharma: Why The Drug Industry Faces A 3-Front Battle With The FTC, Medicare, And The White House

News 14 December 2023 2 Mins Read

The Federal Commission got a big breakthrough this year due to the crusade of drug company deals. It blocks drug companies’ deals to a great extent. On Monday, it ended up with $735 million in licensing deals with the help of Maze Therapeutics.

You need to get through the complete solution of the matter to have a clear idea of it. It was the victory Of FTC chairman Lina Khan. She is starting to make good threats on having a closer look at the smaller deals.

It aims to slow down the growing monopolies in the smaller businesses. The win was a symbol pharmaceutical companies are battling with the US government on several fronts.

Why The Drug Industry Is Facing Three-front Battle In USA?

There are several reasons there why the drug industry is facing the three-front battle in the USA. You cannot ignore the facts at your end. Otherwise, things can become more complex for you in the long run.

  • The Biden Administration is aiming to license the drugs. The main aim behind it is to reduce the cost of some of the drugs in the USA.
  • The government is trying to trigger the March In Rights to bring the situation under control on the USA.
  • Post-COVID-19, there has been a considerable rise in the price of the drugs in the US market. In such a scenario, to reduce the burden on normal people, the Government has taken such a step.

Hence, you must be well aware of the reality while attaining your requirements with ease. Ensure that you know the process from your end to have a better insight to it. You cannot make things happen suddenly. Try to follow the correct process that can make things easier for you in the long run within a specific period of time.

Read More Business News By Clicking Below!!


Leave a Reply

Your email address will not be published. Required fields are marked *

may you also read

ZICO Holdings Inc.'s Puzzling Price-to-Sales Discrepancy Raises Alarms
Oil Prices Were Little Changed As Investors Eye Middle East Tensions, US Rate Cut
Well Positioned For The Millennial Gen Z